
|Articles|September 7, 2006
FDA approves generic ciprofloxacin injection
The FDA has approved several abbreviated new drug applications for generic versions of ciprofloxacin injection for bacterial infections, including urinary tract infections.
Advertisement
The FDA has approved several abbreviated new drug applications for generic versions of ciprofloxacin injection for bacterial infections, including urinary tract infections.
Ciprofloxacin injection USP, 10 mg/mL, is packaged in 20-mL and 40-mL vials and a 120-mL pharmacy bulk package. The products are manufactured by multiple generic drug companies.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Laura Bukavina, MD, and Gabriela Díaz, MD, on the rise of young-onset bladder cancer
3
Individualizing androgen pathway therapy in mCSPC
4
BOND-003 Cohort C: Efficacy Results
5







